{"disease":{"id":"non-alcoholic-fatty-liver-disease-nafld","name":"non alcoholic fatty liver disease nafld"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"pf-05221304","indication_name":"Nonalcoholic fatty liver disease (NAFLD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03151473","title":"Longitudinal Observational Study Of Chinese With NAFLD/NASH","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Humanity and Health Research Centre","has_results":false},{"nct_id":"NCT07241195","title":"A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"The Affiliated Hospital of Hangzhou Normal University","has_results":false},{"nct_id":"NCT04099147","title":"Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.","phase":"","overall_status":"UNKNOWN","enrollment_count":14046,"lead_sponsor_name":"Instituto de Investigación Marqués de Valdecilla","has_results":false},{"nct_id":"NCT03525769","title":"Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05699018","title":"Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":1788,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT06688149","title":"NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":536,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT07180745","title":"Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Badr University","has_results":false},{"nct_id":"NCT05877547","title":"A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05051527","title":"Study to Evaluate the Effectiveness of Legalon®","phase":"","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"Mylan Inc.","has_results":false},{"nct_id":"NCT07265544","title":"Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT02781584","title":"Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03486899","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT04682600","title":"The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF","phase":"NA","overall_status":"UNKNOWN","enrollment_count":164,"lead_sponsor_name":"Sonic Incytes","has_results":false},{"nct_id":"NCT07172997","title":"Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":163,"lead_sponsor_name":"Royal College of Surgeons in Ireland - Medical University of Bahrain","has_results":false},{"nct_id":"NCT03486912","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT06705868","title":"Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Cyprus University of Technology","has_results":false},{"nct_id":"NCT05384652","title":"Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06623084","title":"Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":132,"lead_sponsor_name":"Stefania Basili","has_results":false},{"nct_id":"NCT02217345","title":"Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT03459079","title":"Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT04450875","title":"Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD","phase":"NA","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Universidad Veracruzana","has_results":false},{"nct_id":"NCT02754037","title":"Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT04835831","title":"Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":115,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03572465","title":"Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis","phase":"","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT05908006","title":"Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"GI Alliance","has_results":false},{"nct_id":"NCT03776175","title":"A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04165343","title":"Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT04946786","title":"Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06465186","title":"A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06127225","title":"Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Dexa Medica Group","has_results":false},{"nct_id":"NCT06176079","title":"Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Michael Ohliger, MD PhD","has_results":false},{"nct_id":"NCT02354976","title":"A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04019561","title":"A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"MedImmune LLC","has_results":true},{"nct_id":"NCT07278128","title":"Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Fateme Moshirenia","has_results":false},{"nct_id":"NCT05035043","title":"Economic Burden of NAFLD","phase":"NA","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Hasselt University","has_results":false},{"nct_id":"NCT02196831","title":"Tesamorelin Effects on Liver Fat and Histology in HIV","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT06626074","title":"Exploratory Study of MRI Biomarkers of NASH","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT05216796","title":"Healthy Liver - Healthy Brain","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT04783116","title":"Plant Stanols and Liver Inflammation in Overweight and Obese Children","phase":"NA","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT06727279","title":"Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Federal State Budgetary Scientific Institution \"Federal Research Centre of Nutrition, Biotechnology","has_results":false},{"nct_id":"NCT07093346","title":"The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03042767","title":"Anti-LPS Antibody Treatment for Pediatric NAFLD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Miriam Vos, MD","has_results":true},{"nct_id":"NCT03867487","title":"SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Justin Ryder","has_results":false},{"nct_id":"NCT06338449","title":"The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Xuzhou Medical University","has_results":false},{"nct_id":"NCT04330326","title":"Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"ScandiBio Therapeutics AB","has_results":false},{"nct_id":"NCT03836443","title":"Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05217745","title":"MLCT Oil for Fatty Liver - PASS Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"National University Hospital, Singapore","has_results":false},{"nct_id":"NCT06942312","title":"Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT04282005","title":"Metabolic Surgery for Steato-Hepatitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT07268937","title":"Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}